Automated functional image-guided radiation treatment planning for rectal cancer.

PURPOSE Computer tomography-based (CT-based) tumor-volume definition is time consuming and is subject to clinical interpretation. CT is not accessible for standardized algorithms for the purpose of treatment-volume planning. We have evaluated the accuracy of target-volume definition based on the positron emission tomography (PET) data from an integrated PET/CT system with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) for standardized target-volume delineation. MATERIALS AND METHODS Eleven patients with rectal cancer who were undergoing preoperative radiation therapy (RT) were studied. A standardized region-growing algorithm was tested to replace the CT-derived gross tumor volume by the PET-derived gross tumor volume (PET-GTV) or the biologic target volume (BTV). A software tool was developed to automatically delineate the appropriate tumor volume as defined by the FDG signal, the PET-GTV, and the planning target volume (PTV). The PET-derived volumes were compared with the target volumes from CT. RESULTS The BTV defined for appropriate GTV assessment was set at a single peak threshold of 40% of the signal of interest. Immediate treatment volume definition based on the choice of a single-tumor volume-derived PET-voxel resulted in a tumor volume that strongly correlated with the CT-derived GTV (r(2) = 0.84; p < 0.01) and the volume as assessed on subsequent anatomic-pathologic analysis (r(2) = 0.77; p < 0.01). In providing sufficient extension margins from the CT-derived GTV and the PET-derived GTV, to PTV, respectively, the correlation of the CT-derived and PET-derived PTV was sufficiently accurate for PTV definition for external-beam therapy (r(2) = 0.96; p < 0.01). CONCLUSION Automated segmentation of the PET signal from rectal cancer may allow immediate and sufficiently accurate definition of a preliminary working PTV for preoperative RT. If required, correction for anatomic precision and geometric resolution may be applied in a second step. Computed PET-based target-volume definition could be useful for the definition of standardized simultaneous internal-boost volumes for intensity-modulated radiation therapy (IMRT) based on biologic target volumes.

[1]  E. PeñaydelaPeña,et al.  [Cancer of the rectum]. , 1955, Revista de sanidad militar.

[2]  Cyrill Burger,et al.  Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.

[3]  A. Buck,et al.  PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  R. Thoeni.  Colorectal cancer. Radiologic staging. , 1997, Radiologic clinics of North America.

[5]  A. Figer,et al.  Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. , 2004, Radiology.

[6]  J. Bosset,et al.  Cancer du rectum : volumes cibles de la radiothérapie préopératoire , 2002 .

[7]  R. Drzymala,et al.  Technical aspects of image-based treatment planning of rectal carcinoma. , 2003, Seminars in radiation oncology.

[8]  Icru.  Prescribing, recording, and reporting photon beam therapy , 1993 .

[9]  T. Kato,et al.  Recurrent rectal cancer and scar: differentiation with PET and MR imaging. , 1992, Radiology.

[10]  E van der Schueren,et al.  Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  S. Larson,et al.  A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. , 2003, Journal of the American College of Surgeons.

[12]  Gerald J. Kutcher,et al.  The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer , 2000 .

[13]  John L. Humm,et al.  Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  S M Larson,et al.  Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.

[15]  Curtis B Caldwell,et al.  The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. , 2002, International journal of radiation oncology, biology, physics.

[16]  L. Påhlman.  Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Commentary , 2001 .

[17]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[18]  Yuji Nakamoto,et al.  Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  R. Peto,et al.  Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials , 2001, The Lancet.

[20]  R. Mirimanoff,et al.  Comparison of treatment techniques for lung cancer. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  P. M. Falk,et al.  Positron emission tomography for preoperative staging of colorectal carcinoma , 1994, Diseases of the colon and rectum.

[22]  P. Flamen.  Positron emission tomography in colorectal cancer. , 2002, Best practice & research. Clinical gastroenterology.

[23]  Søren M Bentzen,et al.  High-tech in radiation oncology: should there be a ceiling? , 2004, International journal of radiation oncology, biology, physics.

[24]  N. Petrelli,et al.  Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. , 1995, Radiology.

[25]  Jean-Yves Giraud,et al.  Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Anne Bol,et al.  Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  Peter Kneschaurek,et al.  Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience. , 2003, International journal of radiation oncology, biology, physics.

[28]  Anne Bol,et al.  Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.